Clinical Trial Update: Patients With Brain Metastases From HER2-positive Breast Cancer [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update for patients with brain metastases from HER2-positive breast cancer; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: Institut du Cancer de Montpellier - Val d'Aurelle | Conditions: HER2-positive Breast Cancer | Phase 1 | Status: COMPLETED